Currently, there are 769.67M common shares owned by the public and among those 766.35M shares have been available to trade.
The company’s stock has a 5-day price change of 11.35% and 61.49% over the past three months. XPEV shares are trading -3.15% year to date (YTD), with the 12-month market performance down to -11.69% lower. It has a 12-month low price of $6.55 and touched a high of $16.52 over the same period. XPEV has an average intraday trading volume of 15.27 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.10%, 15.04%, and 52.56% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of XPeng Inc ADR (NYSE: XPEV) shares accounts for 14.33% of the company’s 769.67M shares outstanding.
It has a market capitalization of $10.92B and a beta (3y monthly) value of 2.75. The earnings-per-share (ttm) stands at -$0.86. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.41% over the week and 5.07% over the month.
Earnings per share for the fiscal year are expected to increase by 64.67%, and 53.41% over the next financial year. EPS should grow at an annualized rate of -5.74% over the next five years, compared to -33.39% over the past 5-year period.
China Renaissance coverage for the XPeng Inc ADR (XPEV) stock in a research note released on November 22, 2024 offered a Buy rating with a price target of $16.70. Goldman was of a view on November 21, 2024 that the stock is Neutral, while JP Morgan gave the stock Overweight rating on September 05, 2024, issuing a price target of $8- $11.50. Macquarie on their part issued Outperform rating on August 30, 2024.
